James R. Milligan

Statistics

Publications

Citations

H-Index

Active since

1984

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

James R. Milligan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, nitro compounds, and antifungal therapy.

Publications per year

1984–1991

Publications

Restricticin, a novel glycine-containing antifungal agent.

Robert E. Schwartz, Claude Dufresne, James E. Flor et al. · The Journal of Antibiotics · 1991 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Microbiology +9

Synthesis and stability of N-nitrosodipeptides

Brian C. Challis, James R. Milligan, Robert C. Mithchell · Journal of the Chemical Society Chemical Communications · 1984 · 16 citations

Natural Sciences, Biochemistry, Chemistry +3

The mutagenic properties of N-nitrosopeptides in the Ames test

Brian C. Challis, Andrew R. Hopkins, James R. Milligan et al. · Toxicology Letters · 1985 · 11 citations

Pharmacy, Toxicology, Mechanisms Of Toxicity +7

1–3 of 3